The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, catalysis, medicine, complex systems, ...

FIU professors Angela Laird and Jorge Riera Diaz were recently inducted into the 2024 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Election to the ...

Jaideep Vaidya, a distinguished professor at Rutgers Business School, was recently inducted by the American Institute for Medical and Biological Engineering (AIMBE) to its College of Fellows. The ...

Recycled plastics are promoted on everything from water bottles and fleece jackets to shopping bags and yogurt cups: "This ...

The Department of Chemical and Biological Engineering is updating one of its undergraduate majors to offer students greater flexibility in exploring biological engineering-focused courses. Starting in ...

Northwestern Engineering’s Julio M. Ottino has been elected to the American Institute for Medical and Biological Engineering’s (AIMBE) College of Fellows. AIMBE fellows represent the top 2 percent of ...

Harrison was honored with the Dean’s Award for Achievement, the highest honor presented by the School of Engineering and Applied Sciences, for his commitment to guiding the next generation of ...

Karin Wuertz-Kozak, a faculty researcher at Rochester Institute of Technology, was recently inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

We will conduct innovative research that provides new fundamental knowledge and addresses societal challenges. We conduct impactful chemical and biological engineering research that addresses societal ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the Councils of the National Academy of ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...

High-quality HIV antigens for cutting-edge solutions. On February 18, 2025, Gilead Sciences (CA, US) announced a significant milestone: the US FDA accepted their New Drug Applications (NDAs) for ...